Connect with us

Health

Women under 35 face higher risk of breast cancer spreading – study

breast cancer

Women under 35 face higher risk of breast cancer spreading – study

Women diagnosed with breast cancer under the age of 35 face a higher risk of it spreading, according to the first global study of its kind.

Breast cancer is the most common form of cancer, with 2.3 million people diagnosed every year. Survival rates are generally good, which is largely because of screening, early diagnosis and improved treatment.

However, until now, little has been known about the risk of secondary breast cancer, where the disease spreads to other parts of the body and becomes incurable.

A meta analysis of more than 400 studies has found the risk of breast cancer spreading to another part of the body ranges from 6% to 22%. The results of the study are being presented at the sixth International Consensus Conference for Advanced Breast Cancer .

The findings also suggest certain women face a higher risk, including those diagnosed with breast cancer under the age of 35, those with larger tumours when initially diagnosed and those with specific types of the disease, for example luminal B.

Kotryna Temcinaite, senior research communications manager at the charity Breast Cancer Now, said the analysis “provides helpful insight into who is most at risk”.

“About 1,000 women in the UK die each month from incurable secondary breast cancer,” she said. “We desperately need to learn more about this devastating disease so that we can find new ways to improve treatment, care and support for people living with it, and for those living in fear of a diagnosis.

“The data shows that people diagnosed with primary breast cancer aged 35 years or younger have the greatest chance of developing secondary breast cancer. The study also highlights that the size of the tumour, the type of breast cancer and the length of time since primary diagnosis can impact a person’s risk.

“Secondary breast cancer can develop many years after an initial cancer diagnosis, so it’s vital that we understand it better and find new ways to prevent it.”

For the study, researchers analysed data on tens of thousands of women across more than 400 studies from North and South America, Europe, Africa, Asia and Oceania.

The analysis suggests the overall risk of metastasis for most breast cancer patients is between 6% and 22%. Researchers say the range is broad because the risk varies significantly depending on a whole range of different factors.

For example, women first diagnosed under the age of 35 have a 12.7% to 38% risk of their breast cancer coming back and spreading to other parts of the body, while women aged 50 years or older have a risk of 3.7% to 28.6%.

“This may be because younger women have a more aggressive form of breast cancer or because they are being diagnosed at a later stage,” said the presenter of the study, Dr Eileen Morgan, of the International Agency for Research on Cancer (IARC).

“Breast cancer is the most common form of cancer in the world,” she said. “Most women are diagnosed when their cancer is confined to the breast or has only spread to nearby tissue. But in some women, the cancer will grow and spread to other parts of the body or come back in a different part of the body several years after the end of their initial treatment.

“At this point the cancer becomes much harder to treat and the risk of dying is higher. However, we don’t really know how many people develop metastatic breast cancer because cancer registries have not been routinely collecting this data.”

The study also found women with specific types of breast cancer appeared to have a higher risk of it spreading, for example those with a type of cancer called luminal B.

Those with this form had a 4.2% to 35.5% risk of it spreading compared with 2.3% to 11.8% risk in women diagnosed with luminal A cancer.

Dr Shani Paluch-Shimon, a member of the conference’s scientific committee and director of the breast unit at Hadassah University hospital in Israel, who was not involved with the research, said the findings were “vital” for patients and doctors.

Health

Bayelsa records 98% immunisation coverage

Bayelsa has recorded a 98 per cent coverage in the first round of the 2025 National Immunisation Plus Days (NIPDs) programme conducted from the May 3 to May 6.

Mr Lawrence Ewhrudjakpo, deputy governor of the state, disclosed this during a meeting of the state’s taskforce on immunisation in Yenagoa on Wednesday.

He said that the government’s ultimate target was to achieve 100 per cent coverage in subsequent immunisation campaigns.

Ewhrudjakpo lauded the WHO, UNICEF, the Ministry of Health and other critical stakeholders for the feat achieved so far.

He, however, urged the partners not to rest on their oars as much still have to be done to achieve its target of 100 per cent immunization coverage.

He underscored the need for early preparations ahead of the second round of 2025 NIPDs scheduled for July.

The deputy governor assured the partners that funds for the programme would be released not later than two weeks to its commencement.

He directed all council chairmen to flag-off the second round of the 2025 NIPDs programme at any community other than their respective local government headquarters.

The deputy governor urged the chairmen to meet with the traditional rulers, school proprietors, and religious leaders in their areas to sensitise them on the importance of immunisation.

He also called parents, schools and churches to allow children to participate in the immunisation programme.

”The state government is serious about enforcing its public health law and executive order on compulsory immunisation.

“We have taken our immunisation coverage up to 98 per cent. But we want to take it to 100 per cent this time around, and that is why we have convened this meeting.

“We are also going to make an upward review of the logistics to reflect the present economic realities in the country,” he said.

Presentations by Dr Marcus Oluwadare of the WHO, and Dr Gbanaibulou Orukari, Director of Disease Control, Bayelsa State Primary Healthcare Board, revealed that area councils scored high percentage in the coverage.

They, however, identified poor workload rationalisation, data falsification and lack of commitment on the part of some personnel.

According to Oluwadare, we commend the Deputy Governor of the state for flagging off the NIPDs and chairing all the state ERMs in spite of his tight schedule.

“Bayelsa State was the only state to have full complements of her stakeholders in attendance during the April NIPDs in the whole of Nigeria,” he said.

Continue Reading

Health

NCDC records 832 Lassa fever, Mpox cases, 135 deaths

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed the country has recorded 832 confirmed cases of Lassa fever and Mpox.

Speaking during a press briefing on Friday in Abuja, the agency’s Director General, Dr. Jide Idris, revealed that 132 fatalities were recorded from Lassa fever and three from Mpox.

While acknowledging a recent decline in Lassa fever infections during epidemiological week 16 (ending April 20, 2025), he warned that the overall risk remains high, particularly in endemic regions.

“Cumulatively, as of week 16, Nigeria has reported 4,253 suspected cases of Lassa fever, 696 confirmed cases, and 132 deaths, resulting in a case fatality rate of 19.0 percent,” he stated.

Dr. Idris attributed recent improvements to intensified surveillance, treatment efforts, and enhanced community engagement. He emphasized, however, the continued need for vigilance and collaboration to sustain progress.

Regarding Mpox, the NCDC boss disclosed that three deaths have been recorded in 2025—two in Abia and Ebonyi States in week 10, and one recently in Rivers State involving a patient co-infected with HIV and tuberculosis. As of week 16, 723 suspected cases and 136 laboratory-confirmed cases of Mpox have been reported across 35 states and the Federal Capital Territory (FCT). The national case fatality rate currently stands at 2.2 per cent.

“The epidemic curve reveals multiple peaks in Mpox cases, indicating ongoing transmission. While most states have reported suspected cases, confirmed infections are heavily concentrated in Nigeria’s southern and central regions,” Dr. Idris noted.

To address these outbreaks, the NCDC has activated its Emergency Operations Centre (EOC), deployed National Rapid Response Teams to affected states, and prepositioned essential medical supplies, including personal protective equipment and laboratory consumables. Five additional Mpox diagnostic laboratories have also been optimized in Bauchi, Kano, Cross River, Rivers, and Enugu States.

“Healthcare workers are undergoing specialized training in infection prevention, case management, and cerebrospinal meningitis (CSM) care. Community outreach is being reinforced through public awareness campaigns, media engagement, and targeted health communication strategies,” he added.

On cerebrospinal meningitis, Dr. Idris reported a consistent decline in new cases and fatalities over the last three weeks.

He attributed the improvement to effective vaccination, early treatment, and adaptive surveillance strategies tailored to real-time data.

“Although the situation remains serious, strong national and state-level coordination is showing positive results. The response will continue until full containment is achieved and states take full ownership of the CSM Incident Action Plan,” he said.

Dr. Idris also expressed concern about the rising Mpox trend since its reemergence in 2017, with significant spikes recorded between 2022 and 2024, positioning Nigeria among the most affected countries globally. He warned that underreporting and delayed data entry remain challenges that need urgent resolution to ensure accurate and timely outbreak response.

A national mortality review for the recent Mpox deaths is being planned to further assess response effectiveness and identify areas for improvement.

The NCDC reaffirmed its commitment to safeguarding public health through timely surveillance, transparent reporting, and coordinated national response mechanisms aimed at reducing disease burden and preventing future outbreaks.

Continue Reading

Health

Only 89 doctors left in Kwara Govt hospitals amid ‘Japa’ crisis – Health Board

The Executive Secretary of the Kwara State Hospital Management Board, Abdulrahman Malik, disclosed that there is an acute shortage of medical doctors in the state-owned hospitals.

Speaking at the state interministerial press briefing for the first quarter of 2025 on Tuesday, April 29, Malik said that due to the ‘Japa’ syndrome, doctors do not want to take up appointments with the state government, even when the government is ready to recruit them.

He lamented that while between 180 and 200 doctors are required in the government service, only 89 of them are available in the service.

He said the number of available doctors only recently became 89 from 86 when three who had left the service returned after the government introduced a new and improved salary for the doctors’ services.

The hospital board’s boss said the government had been trying to attract doctors to the state service with improved salaries and facilities that could encourage them to stay, especially in the rural areas where many of them do not want to go.

He also disclosed that the government has introduced an intern nurses programme for the training of nurses who would replace many nurses who had left the service for abroad.

“The mass exodus of health professionals is severely affecting our capacity to provide adequate care,” the official said.

“Gov. AbdulRahman AbdulRazaq has approved an upgrade in the salaries of our doctors to match federal pay in a bid to retain the few we have left.

“The revised salary structure has led to the return of three doctors who had previously resigned, bringing the total number on the state’s payroll to 89.

“However, the figure still falls short of the estimated 180 to 200 physicians needed to serve the state’s population effectively.

“Nigeria’s doctor-to-patient ratio is currently estimated at one doctor to over 5,000 patients, far below the World Health Organisation’s (WHO) recommended one doctor to 600 patients.”

Continue Reading
Advertisement

Trending